Chargement en cours...
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications
The use of posttransplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD) prophylaxis has revolutionized haploidentical hematopoietic stem cell transplantation (HSCT), allowing safe infusion of unmanipulated T cell–replete grafts. PT-Cy selectively eliminates proliferating alloreactive...
Enregistré dans:
| Publié dans: | Blood |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5757695/ https://ncbi.nlm.nih.gov/pubmed/28986344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-05-780668 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|